FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
PO:32:176 | Outcomes of upfront combination vs monotherapy with rituximab or mycophenolate mofetil for systemic sclerosis interstitial lung disease: results from a European Scleroderma Trials and Research cohort study Devis Benfaremo1, Corrado Campochiaro2, Gábor Kumánovics3, Christina Bergmann4, Elisabetta Zanatta5, David Launay6, Serena Guiducci7, Mickael Martin8, Carolina De Souza Müller9, Carlomaurizio Montecucco10, Luc Mouthon11, Gabriella Szucs12, Kastriot Kastrati13, Marie-Elise Truchetet14, Madelon Vonk15, Francesco Del Galdo16, Marco Matucci-Cerinic2, Gianluca Moroncini1, Yannick Allanore17. | 1Department of Clinical and Molecular Sciences, Marche Polytechnic University, Marche University Hospital, Ancona, Italy; 2Vita-Salute San Raffaele University, San Raffaele Hospital, Milano, Italy; 3University of Pécs, Department Of Rheumatology And Immunology, Pécs, Hungary; 4University Hospital Erlangen, Department Internal Medicine 3, Erlangen, Germany; 5Padova University Hospital, Rheumatology Unit, Padova, Italy; 6Univ. Lille, Inserm, CHU Lille, Department of Internal Medicine and Clinical Immunology, Lille, France; 7University of Florence, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy; 8Poitiers University Hospital, Department of Internal Medicine Poitiers France; 9Hospital de Clinicas da Universidade Federal do Parana Curitiba Brazil; 10Università di Pavia e IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy; 11Hôpital Cochin, Department of Internal Medicine, Paris, France; 12University of Debrecen, Faculty of Medicine, Department of Rheumatology, Debrecen, Hungary; 13Medical University of Vienna, Department of Medicine III, Division of Rheumatology, Vienna, Austria; 14CHU de Bordeaux, Rheumatology department, Bordeaux, France; 15Radboudumc, Department of Rheumatology Nijmegen The Netherlands; 16Leeds Raynauds and Scleroderma Program, NIHR Biomedical Research Centre, Leeds, United Kingdom; 17Université Paris Cité, Cochin Hospital, Rheumatology Department, Paris, France.
223 -
PO:08:119 | Infusional Advantage: Rituximab’s Role in Enhancing Adherence in Multimorbid Rheumatoid Arthritis Marco Capodiferro1, Daniele Domanico1, Angelica Napoletano1, Giulia Righetti2, Patrizia Suppressa2, Vincenzo Venerito1, Giuseppe Lopalco1, Florenzo Iannone1, Fabio Cacciapaglia1|2 | 1Rheumatology Unit, Department of Precision and Regenerative Medicine and Jonian Area DiMePRe-J University of Bari, Italy; 2Department of Medicine and Surgery, Miulli General Hospital Acquaviva delle Fonti - LUM University Casamassima Bari Acquaviva delle Fonti, Bari, Italy
40 -
PO:29:145 | Fibromyalgia in idiopathic inflammatory myopathies: is it time for rheumatologists to investigate it? Federico Fattorini1, Michele Diomedi1, Simone Barsotti2, Elenia Laurino3, Chiara Cardelli1|4, Alessandra Tripoli3, Linda Carli3, Marta Mosca1|3. | 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 2Rheumatology, Versilia Hospital, Viareggio, Italy; 3Rheumatology Unit, AOUP, Pisa, Pisa, Italy; 4Department of Medical Biotechnologies, University of Siena, Siena, Italy.
200 -
PO:35:227 | Long-term renal and survival outcomes in microscopic polyangiitis: data from an observational monocentric cohort Roberta Prevedello1, Federica Davanzo1, Luca Iorio1, Eleonora Fiorin1, Marta Codirenzi1, Roberto Padoan1, Andrea Doria1. | 1Unità di Reumatologia, Dipartimento di Medicina DIMED, Università degli Studi di Padova, Padova, Italy.
180 -
PO:15:209 | Attainment of remission or lupus low disease activity state in single center Lupus Clinic Paola Tedoldi1|2, Silvia Ebe Lucia Della Pina1|2, Claudia Barison1|2, Chiara Orlandi1|2, Cecilia Nalli1, Micaela Fredi2, Ilaria Cavazzana1|2, Franco Franceschini1|2 | 1Rheumatology and Clinical Immunology Unit- ERN ReCONNET, ASST Spedali Civili of Brescia Brescia, Italy; 2Department of Clinical and Experimental Sciences, University of Brescia Brescia, Italy
77 -
CO:10:6 | Impact of pregnancy on organ damage in systemic lupus erythematosus: a prospective multicenter study Giancarlo Cascarano1, Greta Hulej2, Dina Zucchi1, Antonia Calligaro2, Elena Elefante1, Luca Iaccarino2, Sabrina Gori1, Margherita Zen2, Chiara Tani1, Andrea Doria2, Marta Mosca1. | 1Università degli Studi di Pisa; 2Università degli Studi di Padova, Italy
205 -
PO:30:153 | Long-term outcomes of JIA-associated uveitis: a systematic review and meta-analysis Laura Scagnellato1, Giacomo Cozzi1, Matteo Molfese1, Mariagrazia Lorenzin1, Jamie Alexander King1, Gianluca Poncina1, Stefano Rizzetto1, Roberta Ramonda1 | 1UOC Reumatologia, Dipartimento di Medicina dei Sistemi DIMED, Ospedale Università di Padova, Italy
108 -
PO:07:108 | Achievement of Treatment Targets and Maintenance of Response with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in a Real-world Setting: Final 2-year Outcomes from the UPHOLD Study Enrico Marchetta1, Andrew Östör2|8, Eugen Feist3, Prodromos Sidiropoulos4, Jérôme Avouac5, Martin Rebella6|7, Rajaie Namas9, Erin Mcdearmon Blondell10, Ivan Lagunes10, Tianming Gao10, Tim Shaw10, Suzan Attar11 | 1AbbVie Srl Roma, Italy; 2Monash University and Emeritus Research, Melbourne, Victoria, Melbourne, Australia; 3Helios Department of Rheumatology and Clinical Immunology, Vogelsang-Gommern, Vogelsang Gommern, Germany; 4Faculty of Medicine, University of Crete, Heraklion, Heraklion, Greece; 5Service de Rhumatologie, Hôpital Cochin, AP HP Centre Université Paris Cité, Parigi, France; 6Departamento de Medicina, Facultad de Medicina, Universidad de la República, Montevideo, Montevideo, Uruguay; 7Unidad de Enfermedades Autoinmunes Sistémicas, MUCAM, Montevideo, Montevideo, Uruguay; 8Australian National University, Camberra, Australia; 9Medical Subspecialties Institute, Division of Rheumatology, Cleveland Clinic Abu Dhabi, United Arab Emirates; 10AbbVie Inc., North Chicago, Illinois, United States of America Chicago, USA; 11King Abdulaziz University, Jeddah, Saudi Arabia
50 -
PO:07:098 | Reasons for treatment failure and their synovial correlate among patients with difficult-to-treat rheumatoid arthritis Alessandro Giollo1, Mariangela Salvato1, Francesca Frizzera1, Kiren Khalid1, Lorenzo Di Luozzo1, Carlo Garaffoni2, Maria Capita2, Marianna Tamussin2, Giovanni Lanza2, Marny Fedrigo3, Annalisa Angelini3, Roberta Ramonda1, Ettore Silvagni2, Andrea Doria1 | 1UOC Reumatologia Padova, Italy; 2UOC Reumatologia Ferrara, Italy; 3UOC Patologia cardiovascolare Padova, Italy; 4UOC Anatomia Patologica Ferrara, Italy
52 -
PO:07:095 | Clinical impact of therapeutic modification following changes in AIFA reimbursement criteria for JAK inhibitors in patients with RA in remission/low disease activity: analysis of the multicenter JAK-SWAP RER study in Emilia-Romagna Marta Raschella1, Giulia Furia1, Martina Di Nunzio1, Francesco Luca Renzullo2, Francesco Girelli2, Federica Pignatti3, Francesco Ursini3, Licia Vultaggio4, Pierluigi Cataleta4, Elena Bravi5, Eugenio Arrigoni5, Francesca Bergossi6, Enrica Vandelli7, Massimo Reta6|7, Viola Magnani8, Andreina Manfredi8|9, Giuseppe Germanò8, Alessandra Bortoluzzi1, Marcello Govoni1, Ettore Silvagni1 | 1Unità Operativa Complessa di Reumatologia, Dipartimento di Scienze Mediche, Università degli Studi di Ferrara e Azienda Ferrara; 2UOS Reumatologia, Ospedale GB Morgagni, Forlì; 3UOC Reumatologia, Istituto ortopedico Rizzoli, Bologna; 4UO Reumatologia, AUSL Romagna Ospedale di Ravenna; 5UO Reumatologia, Azienda USL di Piacenza; 6Reumatologia Osp. Maggiore, Bologna; 7UO Medicina Interna ad Indirizzo Reumatologico Interaziendale SC AUSL Bologna, IRCCS Policlinico di SantOrsola, Bologna; 8U.O Reumatologia, Santa Maria Nuova di Reggio Emilia; 9Università degli studi di Modena e Reggio Emilia, Italy
206 -
PO:35:224 | Capturing What BVAS Misses: Patient-Reported Outcomes Reflect Disease Activity and Burden in EGPA Marta Codirenzi1, Federica Davanzo1, Luca Iorio1, Eleonora Fiorin1, Roberta Prevedello1, Roberto Padoan1, Andrea Doria1 | 1Unità di reumatologia, dipartimento di medicina DIMED,Università degli studi di Padova, Italy
43 -
PO:23:051 | Quantitative high-resolution computed tomography analysis in Sjögren’s disease-associated interstitial lung disease: CALIPER-derived imaging biomarkers for prognostic assessment Gaetano La Rocca1, Francesco Ferro1, Vincenzo Uggenti2, Beatrice Dei1, Giovanni Fulvio1, Michele Moretti1, Chiara Romei2, Marta Mosca1, Chiara Baldini1. | 1University of Pisa, Rheumatology Unit, Clinical and Experimental Medicine Department, Pisa, Italy; 2Department of Diagnostic Imaging, Pisa University Hospital, Pisa, Italy.
212 -
CO:12:5 | Aortic inflammation and aneurysm risk in giant cell arteritis: a multicenter imaging study Caterina Ricordi1, Chiara Marvisi1, Konstanze V. Guggenberger2, Rudolf A. Werner3, Pamela Mancuso8, Giulia Besutti4, Sebastian E. Serfling5, Roberto Farì4, Matthias Frohlich6, Rexhep Durmo7, Michael Gernert6, Lucia Spaggiari4, Annibale Versari7, Paolo Giorgi Rossi8, Pierpaolo Pattacini4, Marc Schmalzing6, Carlo Salvarani1, Thorsten Bley9, Francesco Muratore1. | 1Rheumatology Unit, AUSL IRCCS di Reggio Emilia and Università di Modena e Reggio Emilia, Italy; 2Department of Diagnostic and Interventional Neuroradiology, University Hospital Wuerzburg, Germany; 3Department of Nuclear Medicine, University of Frankfurt, Germany; 4Department of Radiology, AUSL IRCCS di Reggio Emilia, Italy; 5Department of Nuclear Medicine, University Hospital Wuerzburg, Germany; 6Rheumatology and Clinical Immunology, Department of Internal Medicine II, University Hospital Wuerzburg, Germany; 7Nuclear Medicine Unit, AUSL IRCCS di Reggio Emilia, Italy; 8Epidemiology Unit, AUSL-IRCCS di Reggio Emilia, Italy; 9Department of Diagnostic and Interventional Radiology, University Hospital Wuerzburg, Germany
210 -
CO:07:5 | Enhanced fibroblast signatures in females with early rheumatoid arthritis highlights a potential basis for poorer treatment outcomes Benedetta Monosi1, James Perera2, Alessandra Nerviani2|3, Maria Sole Chimenti1, Felice Rivellese2|3, Costantino Pitzalis2|3|4. | 1Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; 2Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK; 3Barts Health NHS Trust and Barts Biomedical Research Centre, National Institute for Health and Care Research, London, UK; 4Department of Biomedical Sciences Humanitas University and IRCCS Humanitas Research Hospital, Milano, Italy
3864 -
PO:23:055 | Overlap of systemic sclerosis and Sjögren’s disease: insights from an Italian case-control study Stefano Stano1, Fabio Cacciapaglia1|2, Maria Morrone1, Simone Perniola1, Marco Capodiferro1, Marco Fornaro1, Laura Coladonato1, Giuseppe Lopalco1, Florenzo Iannone1. | 1Rheumatology Unit - Department of Precision and Regenerative Medicine, Jonian Area DiPReMeJ, University of Bari, Bari, Italy; 2Rheumatology Service, Internal Medicine Unit F. Miulli General Hospital, Department of Medicine and Surgery, LUM Casamassima Italy.
292 -
PO:04:050 | Cluster-Based Endotyping of Psoriatic Arthritis in a Monocentric Italian Cohort: A Real-World study Eneida Cela1, Arianna D'Antonio1, Luigi Fiannacca1, Alberto Bergamini1, Maxime Breban2, Felicie Costantino2, Maria Sole Chimenti1 | 1Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome Tor Vergata Rome, Italy; 2Rheumatology Department, AP-HP, Ambroise-Paré Hospital Paris, France
36 -
CO:09:2 | Mapping Emotional Function in Fibromyalgia: Integrating Alexithymia, Pain Catastrophizing and Self-Compassion Francesca Trunfio1, Damiano Currado1|2, Rosa Bruni3, Barbara Biticchi1, Francesca Saracino1, Erika Corberi1, Ludovica Lamberti1, Annalisa Marino1|2, Lyubomyra Kun1, Leonardo Frasca'1, Sebastiano Lorusso1, Marta Vomero2, Onorina Berardicurti1|2, Roberto Giacomelli1|2, Luca Navarini1|2 | 1Rheumatology and Clinical Immunology, Department of Medicine, University of Rome Campus Biomedico, School of Medicine, Rome, Italy; 2Clinical and Research Section of Rheumatology and Clinical Immunology, Fondazione Policlinico Campus Biomedico, Rome, Italy; 3Psychiatrist, Psychotherapist, certified Teacher Mindful Self-Compassion Program, contract Professor at University Campu Rome, Italy
56 -
PO:26:088 | Rheumatologic immune-related adverse events from immune checkpoint inhibitors: a monocentric retrospective study Giulio Fraticelli1|2, Nicola Farina1|2, Alessandro Tomelleri1|2, Marco Matucci Cerinic1|2, Corrado Campochiaro1|2, Lorenzo Dagna1|2. | 1Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital, Milano, Italy; 2Inflammation, Fibrosis and Ageing Initiative INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy.
206 -
PO:06:094 | Exploring the relationship between inflammation and collagen deposition in synovial tissue and clinical outcomes in active arthritis: insights from a monocentric pilot study Dario Bruno1, Barbara Tolusso1, Daniela Renna1, Mohamed Hegazi2, Fabio Pasqualini2, Marta Caprioli1, Giacomo Maria Guidelli1, Tommaso Hubert3, Nicoletta Luciano1|3, Marzia Monferini3, Natasa Isailovic3, Fabio Grizzi2|3, Salvatorelorenzo Renne3, Costantino Pitzalis1|3|4, Elisa Gremese1|3. | 1Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano (MI); 2Department of Immunology and Inflammation, IRCCS Humanitas Research Hospital, Milano; 3Department of Biomedical Sciences, Humanitas University, Rozzano (MI), Italy; 4Centre for Experimental Medicine and Rheumatology, Queen Mary University of London, London, UK
173 -
PO:01:015 | Assessment of the impact of the co-occurrence of psoriasis on the clinical and therapeutic pattern of a single-centre cohort of patients with spondyloarthritis associated with chronic inflammatory bowel disease Andrea Pace1, Marcella Falconi1, Alberto Floris1|2, Leonardo Sichi1, Francesca Onnis3, Lorenzo Meli3, Raffaela Piras3, Nicola Lutzu3, Federica Olla3, Agnese Favale3, Sara Onali3, Massimo Claudio Fantini3, Matteo Piga1|2, Alberto Cauli1|2. | 1SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari, Cagliari, Italy; 2SC Reumatologia, AOU Cagliari, Cagliari, Italy; 3SC Gastroenterologia, AOU Cagliari, Cagliari, Italy.
215 -
PO:04:046 | Achieving Early Clinical Response was Associated with Cumulative Benefits on Disease Impact up to 2 Years in Patients with Active Psoriatic Arthritis Treated with Bimekizumab William Tillett1|2, Joseph F Merola3, Iain B Mcinnes4, Kenneth B Gordon5, Richard B Warren6, Patrick Healy7, Jérémy Lambert8, Heather Edens9, Barbara Ink10, Paola Volpe11, Laure Gossec12 | 1Royal National Hospital of Rheumatic Diseases Bath, United Kingdom; 2Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath Bath, United Kingdom; 3Department of Dermatology and Department of Medicine, Division of Rheumatology, Utah Southwestern Medical Center Dallas, USA; 4College of Medical Veterinary and Life Sciences, University of Glasgow Glasgow, United Kingdom; 5Department of Dermatology, Medical College of Wisconsin Milwaukee, USA; 6Northern Care Alliance, NHS Foundation Trust and Manchester Academic Health Science Centre, University of Manchester Manchester, United Kingdom; 7UCB Morrisville, USA; 8UCB Colombes, France; 9UCB Smyrna, USA; 10UCB Slough, United Kingdom; 11UOC Reumatologia, P.O. Spirito Santo Pescara, Italy; 12Sorbonne Universite and Pitie-Salpetriere Hospital Paris, France
67 -
PO:14:204 | Risk stratification in systemic lupus erythematosus patients: improving the performances of a prediction model Lucia Lanzo1, Silvia Laura Bosello1, Livia Lilli2, Laura Antenucci2, Carlotta Masciocchi2, Marco Gorini3, Gabriella Castellino3, Luca Petricca1, Maria Rita Gigante1, Vivianaantonella Pacucci1, Pier Giacomo Cerasuolo1, Silvia Piunno1, Francesco Cristiano1, Cesare Gavotti1, Pier Luigi Rizzuti1, Rebecca Ventura1, Jacopo Lenkowicz2, Alfredo Cesario2, Stefano Patarnello2, Maria Antonietta D'Agostino1. | 1UOC di Reumatologia e Immunologia clinica - Fondazione Policlinico Universitario A. Gemelli IRCSS, UCSC, Roma, Italy; 2Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Roma, Italy; 3AstraZeneca MIND, Milano, Italy.
216 -
PO:01:004 | Real-world retention of IL-17 inhibitors in psoriatic arthritis: impact of prior IL-17 exposure across multiple treatment lines in the “BIRRA” multicentre cohort Valentino Paci1, Alarico Ariani2, Eleonora Celletti3, Alberto Lo Gullo4, Camilla Mazzanti5, Valeria Nucera6, Natalia Mansueto7, Rosalba Caccavale8, Patrizia Del Medico9, Antonella Farina10, Palma Scolieri11, Cecilia Giampietro12, Olga Addimanda13, Riccardo Bixio14, Maddalena Larosa15, Viviana Ravagnani16, Federica Lumetti17, Aldo Biagio Molica Colella17, Elena Bravi17, Rosetta Vitetta17, Bernd Raffeiner17, Gilda Sandri18, Rosario Foti19, Simone Parisi20, Michele Maria Luchetti Gentiloni1, Gianluca Moroncini1. | 1Clinical Medicine, Department of Clinical and Molecular Sciences, Marche Polytechnic University, AOU delle Marche, Ancona, Italy; 2Internal Medicine and Rheumatology Unit, University Hospital of Parma, Parma, Italy; 3Rheumatology Unit, Clinica Medica Institute, Ospedale SS. Annunziata di Chieti, G.d'Annunzio University of Chieti, Chieti, Italy; 4Rheumatology Unit, ARNAS Garibaldi di Catania, Catania, Italy; 5Center for the Diagnosis and Therapy of Autoimmune Rheumagological Diseases, Ospedale Santa Rosa, ASL Viterbo Viterbo Italy; 6Rheumatology Outpatient Unit, ASL Novara, Novara, Italy; 7Ambulatori di Reumatologia ASL1 Liguria, Imperia Hospitall Imperia Italy; 8Department of Clinical, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Polo Pontino, Roma, Italy; 9Rheumatology outpatient clinic - Internal Medicine Unit, Civitanova Marche Hospital, Civitanova Marche, Italy; 10Internal Medicine Unit, Rheumatology outpatient clinic, Ospedale A. Murri di Fermo, Fermo, Italy; 11Department of Medical Specialties, Nuovo Regina Margherita Hospital, Rome, Roma, Italy; 12Rheumatology Outpatient Clinic, Azienda ULSS 6 Euganea, Padova, Padova, Italy; 13Rheumatology Unit, Azienda Unità Sanitaria Locale di Bologna -- Policlinico S.Orsola- AOU di Bologna, Bologna, Italy; 14Rheumatology Unit, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy; 15Division of Rheumatology - Medical Specialties Department, Ospedale La Colletta-Azienda Sanitaria Locale 3, Genova, Italy; 16Rheumatology Unit, Santa Chiara Hospital APSS Trento Italy; 17BIRRA - BIologic Retention Rate in chronic Arthritis - study group, Parma, Italy; 18Rheumatology Unit, University of Modena and Reggio Emilia, Modena, Italy; 19Rheumatology Unit, Policlinico San Marco Hospital, Catania, Italy; 20Rheumatology Department, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
287 -
PO:01:015 | Evaluation of the impact of concomitant psoriasis on the clinical and therapeutic pattern of a monocentric cohort of patients affected by spondyloarthritis associated with inflammatory bowel diseases Andrea Pace1, Marcella Falconi1, Alberto Floris1|2, Leonardo Sichi1, Francesca Onnis3, Lorenzo Meli3, Raffaela Piras3, Nicola Lutzu3, Federica Olla3, Agnese Favale3, Sara Onali3, Massimo Claudio Fantini3, Matteo Piga1|2, Alberto Cauli1|2 | 1SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari; 2SC Reumatologia, AOU Cagliari; 3SC Gastroenterologia, AOU Cagliari, Italy
169 -
CO:05:4 | Natural language processing reveals demographic features, comorbidities, and clinical domains to predict treatment longevity of b/tsDMARDs in psoriatic arthritis Antonio Tonutti1|2, Pierandrea Morandini3, Cosimo Faeti3, Nicoletta Luciano1|2, Saverio D'Amico3, Victor Savevski3, Carlo Selmi1|2 | 1Department of Biomedical Sciences, Humanitas University Pieve Emanuele, Milan, Italy; 2Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; 3Artificial Intelligence Unit, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy
85 -
PO:13:189 | Greater impact of psoriatic arthritis in females: is this mediated primarily by disease activity? Roberta Masnata1, Valentina Boni1, Giusy Peluso1, Giulia Calabrese1, Enrico De Lorenzis1, Gerlando Natalello1, Maria Antonietta D'Agostino1, Augusta Ortolan1. | 1UOC Reumatologia e Immunologia Clinica- Fondazione Policlinico Agostino Gemelli IRCCS-Università Cattolica Sacro Cuore, Roma, Italy.
189 -
PO:33:203 | Efficacy and safety of rituximab in eosinophilic fasciitis: report of three cases and systematic literature review Andrea Benini1, Beatrice Moccaldi1, Marco Binda1, Anna Cuberli1, Mariangela Favaro1, Andrea Doria1, Elisabetta Zanatta1 | 1UOC Reumatologia, Azienda Ospedale, Università di Padova, Italy
263 -
PO:34:214 | Autonomic Symptoms Are Associated with Neuropathic Pain Features and Disease Impact in Systemic Sclerosis: Results From a Cross-Sectional Study Benedetta Bianchi1, Francesca Francioso1, Mariachiara Mangiafico1, Fausto Salaffi1, Rossella De Angelis1, Marco Di Carlo1 | 1U.O. Reumatologia, Ospedale Carlo Urbani, Università Politecnica delle Marche Jesi, Italy
51 -
PO:31:166 | S'/PAPs ratio in systemic sclerosis: a promising non-invasive index for early detection and prognosis of pulmonary hypertension. A step toward more accurate screening? Marco De Pinto1, Amelia Spinella1, Pierluca Macripò2, Alessia Laneri1, Benedetta Bongiovanni1, Maria Grazia Malandra1, Martina Orlandi1-3, Gianluca Pagnoni2, Arianna Maini2, Rosario Rossi2-4, Clodoveo Ferri1, Francesca Coppi2-3, Dilia Giuggioli1-3. | 1Rheumatology Unit, Azienda Ospedaliero-Universitaria Policlinico di Modena, University of Modena and Reggio Emilia, Modena, Italy; 2Cardiology Division, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy; 3Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy; 4Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
222 -
PO:02:017 | Difficult-to-treat psoriatic arthritis: clinical and ultrasonographic predictors in a real-life cohort Federico Favaro1, Elisa Bellis1, Claudio Cruciani1, Gloria Crepaldi1, Valeria Data1, Claudia Garulli1, Claudia Lomater1, Elena Marucco1, Marta Saracco1, Mariele Gatto1, Annamaria Iagnocco1. | 1Academic Rheumatology Centre, Departement of Clinical and Biological Sciences, University of Turin, AO Mauriziano, Torino, Italy.
187 -
PO:20:014 | Post-partum osteoporosis: severe clinical presentation in absence of known risk factors Domenico Birra1, Ludovica Frances Grasso2, Vittoria Gammaldi1, Antonietta De Sena1, Carmine Pio Petrosino2, Rosalia Boccia2, Gabriella Oliva1, Vincenzo Nuzzo1 | 1Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma; 2Istituto Superiore di Sanità, Roma
219
